Pancreapar (Energique, Inc.)


Welcome to the PulseAid listing for the Pancreapar drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Energique, Inc.
NON-PROPRIETARY NAME: Hydrastis Canadensis, Syzygium Jambolanum, Glandula Suprarenalis Suis, Pancreas Suis, Pituitary, Phaseolus
SUBSTANCE NAME: GOLDENSEAL; SYZYGIUM CUMINI SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; KIDNEY BEAN; ACETIC ACID; LACTIC ACID; PHOSPHORIC ACID; PHOSPHORUS; URANYL NITRATE HEXAHYDR
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2013-04-11
END MARKETING DATE: 0000-00-00


Pancreapar HUMAN OTC DRUG Details:

Item DescriptionPancreapar from Energique, Inc.
LABELER NAME: Energique, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 6; 6; 6; 9; 12; 12; 12; 12; 12([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2013-04-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44911-0075_5b166a19-d1fa-4713-9fe6-3a1c65b7f300
PRODUCT NDC: 44911-0075
APPLICATION NUMBER:

Other GOLDENSEAL; SYZYGIUM CUMINI SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; KIDNEY BEAN; ACETIC ACID; LACTIC ACID; PHOSPHORIC ACID; PHOSPHORUS; URANYL NITRATE HEXAHYDR Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Energique, Inc.Pancreapar